Incorporating mechanistic data into risk assessment

Toxicology

Volumn 181-182, Issue , 2002, Pages 271-274

  Lehman McKeeman, Lois D ^a,b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Choline deficiency; Diethanolamine; Mechanisms; Risk assessment

Indexed keywords

ALKANOLAMINE; CARCINOGEN;

ANIMAL CELL; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; CHO CELLS; CHOLINE DEFICIENCY; CRICETINAE; ETHANOLAMINES; HUMANS; MICE; RATS; RISK ASSESSMENT; S-ADENOSYLMETHIONINE;

EID: 0037184850     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00454-7     Document Type: Article

References (15)

1. Counts J.L., Sarmiento J.I., Harbison M.L., Downing J.C., McClain R.M., Goodman J.I. Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration. Carcinogenesis. 17:1996;1251-1257.
2. Hoffbauer F.W., Zaki F.G. Choline deficiency in baboon and rat compared. Arch. Pathol. 79:1965;364-369.
3. International Agency for Research on Cancer, 1999. Consensus report. In: McGregor, D.B., Rice, J.M., Venitt, S. (eds.), The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation. IARC Publications, No. 146, Lyon, pp. 1-18.
4. IPCS, 1999. IPCS workshop on developing a conceptual framework for cancer risk assessment, 16-18 February 1999, Lyon France, IPCS/99.6.
5. Knaak J.B., Leung H.-W., Stott W.T., Busch J., Bilsky J. Toxicology of mono-, di- and triethanolamine. Rev. Environ. Contam. Toxicol. 149:1997;1-86.
6. Lehman-McKeeman L.D., Gamsky E.A. Diethanolamine inhibits choline uptake and phosphatidylcholine synthesis in Chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 262:1999;600-604.
7. Lehman-McKeeman L.D., Gamsky E.A. Choline supplementation prevents diethanolamine-induced morphological transformation in Syrian hamster embryo cells: evidence for a carcinogenic mechanism. Toxicol. Sci. 55:2000;303-310.
8. Mathews J.M., Garner C.E., Black S.L., Matthews H.B. Diethanolamine absorption, metabolism and disposition in rat and mouse following oral, intravenous and dermal administration. Xenobiotica. 27:1997;733-746.
9. National Toxicology Program, 1999. Toxicology and carcinogenesis studies of diethanolamine in F344/N and B6C3F1 mice (Dermal Studies). NTP TR 478.
10. Pomfret E.A., daCosta K.-A., Zeisel S.H. Effects of choline deficiency and methotrexate up on rat liver. J. Nutr. Biochem. 1:1990;533-541.
11. Rogers A.E., Nields H.M., Newberne P.M. Nutritional and dietary influences on liver carcinogenesis in mice and rats. Arch. Toxicol. Suppl. 10:1987;231-243.
12. Sidransky H., Farber E. Liver choline oxidase activity in man and in several species of animals. Arch. Biochem. Biophys. 87:1960;129-133.
13. Stott W.T., Bartels M.J., Brzak K.A., Mar M.-H., Markham D.A., Thorton C.M., Zeisel S.H. Potential mechanisms of tumorigenic action of diethanolamine in mice. Toxicol. Lett. 114:2000;67-75.
14. USEPA, 1996. Proposed guidelines for carcinogen risk assessment. Fed. Reg. 61, pp. 17960-18011.
15. Zeisel S.H., Blusztajn J.K. Choline and human nutrition. Annu. Rev. Nutr. 14:1994;269-296.